The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: prednisolone     Quarter: 2016Q3

Total Drug/Injury Combinations: 1,369     Number of Pages: 69

DRUGNAME PT EventCount
PREDNISOLONE, 5 % Eye pain 1 view events
PREDNISOLONE, 5 % Mental impairment 1 view events
PREDNISOLONE, 5 % Ocular hyperaemia 1 view events
PREDNISOLONE, CICLOSPORIN Hepatitis 1 view events
PREDNISOLONE, CICLOSPORIN Hepatitis B 1 view events
PREDNISOLONE. Abortion induced 1 view events
PREDNISOLONE. Abscess 1 view events
PREDNISOLONE. Abulia 1 view events
PREDNISOLONE. Acne 1 view events
PREDNISOLONE. Acute graft versus host disease 1 view events
PREDNISOLONE. Acute hepatic failure 1 view events
PREDNISOLONE. Acute lymphocytic leukaemia 1 view events
PREDNISOLONE. Acute respiratory failure 1 view events
PREDNISOLONE. Adenocarcinoma 1 view events
PREDNISOLONE. Adenocarcinoma of colon 1 view events
PREDNISOLONE. Adenovirus infection 1 view events
PREDNISOLONE. Adrenal disorder 1 view events
PREDNISOLONE. Adverse event 1 view events
PREDNISOLONE. Affective disorder 1 view events
PREDNISOLONE. Agitation 1 view events

Total Drug/Injury Combinations: 1,369     Number of Pages: 69

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)